Philip D. Harvey

Relationship between cortisol and age-related memory impairments in Holocaust survivors with PTSD.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.

Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.

Depressed mood and its functional correlates in institutionalized schizophrenia patients.

Learning and memory in aging combat veterans with PTSD.

Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.

Cognition in schizophrenia: impairments, determinants, and functional importance.

Conference report: the Seventh Biennial Mt. Sinai Conference on Cognition in Schizophrenia.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Negative symptoms and cognitive deficits: what is the nature of their relationship?

The validation of a caregiver assessment of dementia: the Dementia Severity Scale.

Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia.

Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients.

From clinical research to clinical practice: a 4-year review of ziprasidone.

Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors.

Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia.

Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders.

The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.

Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.

Dispositional impulsivity in normal and abnormal samples.

Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.

Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.

Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study.

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.

Convergence of clinical staff ratings and research ratings to assess patients with schizophrenia in nursing homes.

The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Premorbid functioning and treatment response in recent-onset schizophrenia.

Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity.

Treatment of cognitive deficits in schizophrenia.

Memory performance in older trauma survivors: implications for the longitudinal course of PTSD.

Pharmacological approaches to the management of cognitive dysfunction in schizophrenia.

Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics.

Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop.

The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.

Defining and achieving recovery from bipolar disorder.

Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?

Longitudinal assessment of cognitive performance in Holocaust survivors with and without PTSD.

Self-assessment of functional status in schizophrenia.

Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.

Big Brother and AIDS: DKT International vs. USAID.

Cognitive and functional effects of atypical antipsychotic medications.

Outcomes to monitor when treating bipolar disorder or schizophrenia.

Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum.

Schizophrenia from a neuropsychiatric perspective.

Risperidone and cognitive function in children with disruptive behavior disorders.

Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia.

Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable?

Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognition.

Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD.

Administration and interpretation of the Trail Making Test.

Performance-based measures of functional skills: usefulness in clinical treatment studies.

The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.

Cognition and aging in psychopathology: focus on schizophrenia and depression.

Schizophrenia: measurements of psychopathology.

Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.

Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.

Managing cognitive deficits and functioning in patients with schizophrenia.

Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests.

A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.

Is schizophrenia a syndrome of accelerated aging?

Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia.

A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia.

The broad importance of cognitive impairments in aging-related disorders.

Pharmacological treatment of cognition in schizophrenia: an idea whose method has come.

Introduction to the special section: The Eighth Biennial Mt. Sinai Conference on Cognition in Schizophrenia.

Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study.

The importance of pleasure.

Cognition and the differential diagnosis of schizophrenia.

Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum.

Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).

Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.

Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.

Social marketing: no longer a sideshow.

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Communication abnormalities predict functional outcomes in chronic schizophrenia: differential associations with social and adaptive functions.

The importance of pleasure.

Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service.

Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome.

Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia.

Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.

Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?

Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol.

Long-term effects of rivastigmine capsules in patients with traumatic brain injury.

Depression in schizophrenia: methodological artifact or distinct feature of the illness?

Functional recovery in schizophrenia: raising the bar for outcomes in people with schizophrenia.

Neurocognitive impairment in bipolar disorder patients: functional implications.

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

The factor structure of clinical symptoms in depressed inpatients with unipolar or bipolar spectrum disorders: a preliminary study.

Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions.

Evaluation of dementia rating scales in Parkinson's disease dementia.

Cognitive deficits and functional outcome in schizophrenia.

A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder.

Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.

Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.

Pharmacological cognitive enhancement in schizophrenia.

Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel.

The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder.

The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.

Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study.

Effects of lithium on cognitive performance: a meta-analysis.

Is it possible to assess cognitive impairment other than with neuropsychological tests?

When does cognitive decline occur in the period prior to the first episode of schizophrenia?

The genetics of cognitive impairment in schizophrenia.

CNTRICS: Bringing Clinical Treatment Trials Closer to the Brain.

Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms.

Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.

Direct measurement of disability.

Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies.

Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum.

Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.

The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay.

Correlates of recovery of social functioning in types I and II bipolar disorder patients.

Social cognition: the key factor predicting social outcome in people with schizophrenia?

Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change.

The Latest Developments in the MATRICS Initiative.

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

Is cognitive impairment in schizophrenia multidimensional?: implications for assessment and treatment.

Cognitive Outcomes in the CATIE Schizophrenia Trial: Why do they seem different from previous results?

Factors associated with functional recovery in bipolar disorder patients.

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

Psychometric properties of a short form of the Affective Lability Scale (ALS-18).

Latest developments in the matrics process.

The effects of hypertension and body mass index on cognition in schizophrenia.

Cognition and disability in bipolar disorder: lessons from schizophrenia research.

Will improving cognition change functional outcomes in schizophrenia?

Cognitive impairments in major depression and bipolar disorders.

Current Status of the MATRICS/ TURNS Initiative.

Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PET.

Differential effects of emotional information on interference task performance across the life span.

Using new antipsychotics in your clinical practice.

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.

Social competence and observer-rated social functioning in bipolar disorder.

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.

Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia.

Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in China.

International assessment of functional skills in people with schizophrenia.

Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.

In family planning service programmes 'coordination' is greatly overrated.

Impairment in functional capacity as an endophenotype candidate in severe mental illness.

Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.

Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.

Assessing everyday functioning in schizophrenia: not all informants seem equally informative.

Assessment of everyday functioning in schizophrenia.

Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia.

Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.

Schizophrenia in later life.

Determinants of occupational and residential functioning in bipolar disorder.

Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults.

Mood symptoms, cognition, and everyday functioning: in major depression, bipolar disorder, and schizophrenia.

Prevalence and precursors of the use of restraint and seclusion in a private psychiatric hospital: comparison of child and adolescent patients.

The influence of demographic factors on functional capacity and everyday functional outcomes in schizophrenia.

The effects of child abuse and neglect on cognitive functioning in adulthood.

Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.

Profile of female sterilisation clients at eight clinics in Eastern India.

Diagnosis of schizophrenia: consistency across information sources and stability of the condition.

Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation.

Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder.

Clinical applications of neuropsychological assessment.

Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.

Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants.

Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Cognitive remediation in severe mental illness.

Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validity.

Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings.

Cognitive impairment in schizophrenia.

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Future directions for social cognitive interventions in schizophrenia.

Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness.

Technology, society, and mental illness: challenges and opportunities for assessment and treatment.

Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder.

Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability.

Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.

Latent semantic variables are associated with formal thought disorder and adaptive behavior in older inpatients with schizophrenia.

The convergence between self-reports and observer ratings of financial skills and direct assessment of financial capabilities in patients with schizophrenia: more detail is not always better.

Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation.

Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms.

Commentary on "Cognition in schizophrenia".

The Social Cognition Psychometric Evaluation Study: Results of the Expert Survey and RAND Panel.

Systematic Study of Structured Diagnostic Procedures in Outpatient Psychiatric Rehabilitation: A Three-year, Three-cohort Study of the Stability of Psychiatric Diagnoses.

Vocational functioning in schizotypal and paranoid personality disorders.

Neurocognition, functional capacity, and functional outcomes: the cost of inexperience.

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.

Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder.

Treatment of obesity and disability in schizophrenia.

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.

Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes.

Disability in schizophrenia: contributing factors and validated assessments.

Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia.

Toward an Understanding of Decision Making in Severe Mental Illness.

Discovery of previously undetected intellectual disability by psychological assessment: A study of consecutively referred child and adolescent psychiatric inpatients.

Cognitive Effects of Quetiapine XR in Patients With Euthymic Bipolar Disorder.

Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia.

What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia?

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.

Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports.

Impulsive choice and psychological pain in acutely suicidal depressed patients.

The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls.

The Course and Correlates of Everyday Functioning in Schizophrenia.

Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.

Virtual Reality Functional Capacity Assessment In Schizophrenia: Preliminary Data Regarding Feasibility and Correlations with Cognitive and Functional Capacity Performance.

Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies.

Cognition in schizophrenia: Past, present, and future.

The course of vocational functioning in patients with schizophrenia: Re-examining social drift.

A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia.

Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia.

Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness.

Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning.

Long-term psychiatric outcomes in pediatric brain tumor survivors.

Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.

Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study.

Methods for delivering and evaluating the efficacy of cognitive enhancement.

The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.

Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary study.

Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study.

Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia.

Social cognition, social competence, negative symptoms and social outcomes: Inter-relationships in people with schizophrenia.

Clozapine improves the orienting of attention in schizophrenia.

Cognitive aspects of schizophrenia.

Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study.

Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder.

The Happy Older Latinos are Active (HOLA) health promotion and prevention study: study protocol for a pilot randomized controlled trial.

Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies.

Neurocognitive insight and objective cognitive functioning in schizophrenia.

Treatment resistant schizophrenia: Course of brain structure and function.

Insight and subjective measures of quality of life in chronic schizophrenia.

Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.

Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis.

Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials.

Social cognition in schizophrenia: Factor structure of emotion processing and theory of mind.

Depression in Schizophrenia: Associations With Cognition, Functional Capacity, Everyday Functioning, and Self-Assessment.

Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting.

Dr Kantrowitz and Colleagues Reply.

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study.

Assessing functional performance using computer-based simulations of everyday activities.

PARANOID INDIVIDUALS WITH SCHIZOPHRENIA SHOW GREATER SOCIAL COGNITIVE BIAS AND WORSE SOCIAL FUNCTIONING THAN NON-PARANOID INDIVIDUALS WITH SCHIZOPHRENIA.

Impact of genotyping errors on statistical power of association tests in genomic analyses: A case study.

The Effect of Age, Race, and Sex on Social Cognitive Performance in Individuals With Schizophrenia.

Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder.

Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.

A Novel Method for Direct Assessment of Everyday Competence Among Older Adults.

Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?

Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis.

Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief.

Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia.

Social Cognition Psychometric Evaluation: Results of the Final Validation Study.

Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.

What Is So Different About Psychotic Patients Who Have Extremely Long Institutional Stays?

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data.

Social Skills Training for Negative Symptoms of Schizophrenia.

Utility of the UCSD Performance-based Skills Assessment-Brief Japanese version: discriminative ability and relation to neurocognition.

Editorial.

Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels.

Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder: Investigation of Placebo Response in a Pharmacological Treatment Study of Post-Traumatic Stress Disorder.

Interpersonal beliefs related to suicide and facial emotion processing in psychotic disorders.

Self-assessment of social cognitive ability in schizophrenia: Association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes.

Suicidal ideation and behavior in US veterans with schizophrenia or bipolar disorder.

Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis.

Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?

Social cognitive impairments in individuals with schizophrenia vary in severity.

Paranoia and interpersonal functioning across the continuum from healthy to pathological - Network analysis.

Combining training leads to better results: Implications for clinical delivery of computerized cognitive and social cognitive training.

Neural correlates of social cognitive introspective accuracy in schizophrenia.

Social Cognition and Neurocognition in Schizophrenia and Healthy Controls: Intercorrelations of Performance and Effects of Manipulations Aimed at Increasing Task Difficulty.

Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ).

Controversies in Computerized Cognitive Training.

Social cognition and short-term prediction of suicidal ideation in schizophrenia.

Cigarette Smoking, Cognitive Performance, and Severe Mental Illness: Quitting Smoking Really Does Seem to Matter.

Predictors of social functioning in patients with higher and lower levels of reduced emotional experience: Social cognition, social competence, and symptom severity.

Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes.

Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.

Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes.

Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes.

Smoking Cannabis and Acquired Impairments in Cognition: Starting Early Seems Like a Really Bad Idea.

The International Consortium Investigating Neurocognition in Bipolar Disorder (ICONIC-BD).

Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study.

Cognition and disability in schizophrenia: cognition-related skills deficits and decision-making challenges add to morbidity.

Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning.

Functional deficits in attenuated psychosis syndrome and related conditions: Current and future treatment options.

Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS).

Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis.

Effects of Roluperidone (MIN-101) on two dimensions of the negative symptoms factor score: Reduced emotional experience and reduced emotional expression.

What Do People With Schizophrenia Do All Day? Ecological Momentary Assessment of Real-World Functioning in Schizophrenia.

Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder.

Comprehensive comparison of social cognitive performance in autism spectrum disorder and schizophrenia.

Correlates of loneliness among persons with psychotic disorders.

Cognition, Social Cognition, and Functional Capacity in Early-Onset Schizophrenia.

Domains of cognition and their assessment
.

Autistic symptoms predict social cognitive performance in patients with schizophrenia.

Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls.

Training engagement, baseline cognitive functioning, and cognitive gains with computerized cognitive training: A cross-diagnostic study.

Cyberbullying and Its Relationship to Current Symptoms and History of Early Life Trauma: A Study of Adolescents in an Acute Inpatient Psychiatric Unit.

Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial.